Using the ACT Network to Gain Insight into COVID-19
As part of AMIA's ongoing COVID-19 Webinar Series, they will take a look at how the Clinical Research Informatics community is contributing to better understanding the clinical nature of the coronavirus. Members of the Accrual to Clinical Trials (ACT) network will present an overview of the existing network, and will describe the goals of the ACT COVID-19 project. Join AMIA on May 5, 4:00 - 5:00 PM for a COVID-19 Webinar
Presenters will discuss how they have been able to apply proven ACT technology, governance and Data Use Agreements to quickly implement a scalable COVID-19 research platform. Specifically, they will focus on COVID-19 extensions to the ACT query ontology, rapid implementation of a COVID-19 focused subnetwork and our process to rapidly design, develop, implement, evaluate and incrementally improve to meet the changing needs of COVID-19 research. Attendees will be able to understand how ACT fits into the variety of other efforts focused on COVID-19 research and how they can use the ACT and ACT COVID-19 project for their research.
Presenters:Lee Nadler, MD
Dean, Clinical and Translational Research
Harvard Medical School
Principal Investigator
Harvard Catalyst
Shawn Murphy, M.D., Ph.D
Professor of Neurology and Biomedical Informatics at Harvard Medical School
Chief Research Information Officer at Partners, HealthCare
Associate Director of the Lab of Computer Science at MGH
Shyam Visweswaran, MD, PhD
Director of Clinical Informatics
Department of Biomedical Informatics
University of Pittsburgh
Douglas MacFadden
Chief Informatics Officer, Harvard Catalyst
Harvard Medical School